Protiva Biotherapeutics, Inc.
Records under this name other than the patents Protiva Biotherapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Protiva Biotherapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,745,651 | Cationic lipids and methods of use Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,642,076 | Lipid Containing Formulations Formerly held In force · Low confidence | In force | Low confidence | |
| US 8,188,263 | Modified siRNA molecules and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,814,777 | Targeting Lipids Formerly held In force (reinstated) · High confidence | In force (reinstated) | High confidence | |
| US 9,006,191 | Silencing of polo-like kinase expression using interfering RNA Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,058,069 | Lipid formulations for nucleic acid delivery Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,822,668 | Lipid formulations for nucleic acid delivery Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,364,435 | Lipid formulations for nucleic acid delivery Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,141,378 | Lipid formulations for nucleic acid delivery Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,492,359 | Lipid formulations for nucleic acid delivery Formerly held In force · USPTO record | In force | USPTO record |